Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1980;61:931-937

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ader, R.
Right arrow Articles by Parmley, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ader, R.
Right arrow Articles by Parmley, W.

Circulation, Vol 61, 931-937, Copyright © 1980 by American Heart Association


ARTICLES

Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor

R Ader, K Chatterjee, T Ports, B Brundage, B Hiramatsu and W Parmley

The hemodynamic effects of an oral angiotensin-converting enzyme inhibitor, captopril, were evaluated in 10 symptomatic patients with chronic congestive heart failure. In all patients there was a significant increase in cardiac output (average 28%), stroke volume (49%), and stroke work index (26%), along with a decrease in pulmonary capillary wedge pressure (48%), indicating improved left ventricular function. Modest decreases in heart rate and arterial pressure were also observed. In seven patients maintained on captopril therapy, repeat hemodynamic studies at 2 months revealed sustained effects. These beneficial hemodynamic effects were accompanied by clinical improvement and improved exercise tolerance during maintenance therapy. These findings suggest that captopril may be a useful therapeutic adjunct for the long-term management of patients with chronic congestive heart failure.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
M. E. Khalil, A. W. Basher, E. J. Brown Jr, and I. A. Alhaddad
A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1757 - 1764.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. N. Nanas, G. Alexopoulos, M. I. Anastasiou-Nana, K. Karidis, A. Tirologos, S. Zobolos, V. Pirgakis, L. Anthopoulos, D. Sideris, S. F. Stamatelopoulos, et al.
Outcome of patients with congestive heart failure treated with standard versus high doses of enalapril: a multicenter study
J. Am. Coll. Cardiol., December 1, 2000; 36(7): 2090 - 2095.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. Packer, P. A. Poole-Wilson, P. W. Armstrong, J. G. F. Cleland, J. D. Horowitz, B. M. Massie, L. Ryden, K. Thygesen, and B. F. Uretsky
Comparative Effects of Low and High Doses of the Angiotensin-Converting Enzyme Inhibitor, Lisinopril, on Morbidity and Mortality in Chronic Heart Failure
Circulation, December 7, 1999; 100(23): 2312 - 2318.
[Abstract] [Full Text] [PDF]


Home page
Anesth. Analg.Home page
P. Colson, F. Ryckwaert, and P. Coriat
Renin Angiotensin System Antagonists and Anesthesia
Anesth. Analg., November 1, 1999; 89(5): 1143 - 1143.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
D. L. Groden
Vasodilator Therapy for Congestive Heart Failure: Lessons From Mortality Trials
Arch Intern Med, February 22, 1993; 153(4): 445 - 454.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
P. C. Deedwania
Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure
Arch Intern Med, September 1, 1990; 150(9): 1798 - 1805.
[Abstract] [PDF]


Home page
Journal of Pharmacy PracticeHome page
M. A. Munger, S. F. Gardner, and R. C. Jarvis
Endocrinologic Warfare: The Role of Angiotensin-Converting Enzyme Inhibitors in Congestive Heart Failure
Journal of Pharmacy Practice, January 1, 1990; 3(5): 318 - 331.
[Abstract] [PDF]


Home page
JAMAHome page
W. L. Augenstein, K. W. Kulig, and B. H. Rumack
Captopril Overdose Resulting in Hypotension
JAMA, June 10, 1988; 259(22): 3302 - 3305.
[Abstract] [PDF]


Home page
ScienceHome page
P. Pion, M. Kittleson, Q. Rogers, and J. Morris
Myocardial failure in cats associated with low plasma taurine: a reversible cardiomyopathy
Science, August 14, 1987; 237(4816): 764 - 768.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M. PACKER, W. H. LEE, N. MEDINA, and M. YUSHAK
Influence of Renal Function on the Hemodynamic and Clinical Responses to Long-Term Captopril Therapy in Severe Chronic Heart Failure
Ann Intern Med, February 1, 1986; 104(2): 147 - 154.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
G. S. FRANCIS, S. R. GOLDSMITH, T. B. LEVINE, M. T. OLIVARI, and J. N. COHN
The Neurohumoral Axis in Congestive Heart Failure
Ann Intern Med, September 1, 1984; 101(3): 370 - 377.
[Abstract] [PDF]


Home page
JAMAHome page
R. K. Ferguson, H. H. Rotmensch, and P. H. Vlasses
Clinical Use of Captopril: Illustrative Cases
JAMA, April 16, 1982; 247(15): 2117 - 2119.
[Abstract] [PDF]